Madelung Disease: Analysis of Clinicopathological Experience in Taipei Veterans General Hospital

Background The main feature of Madelung disease (MD), a rare condition, is the growth of adipose tissue without a capsule. Usually, this disease is known for its prominent features with fat deposition around the neck, shoulder, back, or chest wall. Clinically, the patient is likely to exhibit alcohol, neuropathy, and metabolic disorders; however, no clear cause has been confirmed. Aims The aim of this study was to analyze the morphological, pathophysiological, and various treatment methods of MD. We have presented and discussed 16 cases of treatment of this disease at our hospital and reviewed the literature on this subject. Methods We carried out a retrospective chart review of 16 consecutive patients with MD treated from 1989 through 2017. Patient demographic data, tumor size and location, and follow-up data were evaluated. Patients usually seek treatment because of the disfigured appearance, restricted range of the motion of the head and neck, inconvenience in daily activity such as eating or speaking, and worry about the mass effect. All patients underwent surgical resection and/or combined liposuction. Results Among the patients, 14 were men, aged 38 to 80 years, with a history of disease ranging from 6 months to 7 years. The mean duration from symptoms to diagnosis of MD was 4.4 years. The mean duration of follow-up was 82.8 months (range, 5–192 months). Three patients died of coronary artery disease at follow-up of 27, 78, and 141 months. The functional results were satisfactory in all patients. Severe complications were not observed. Conclusions According to our experience, surgical resection is the main method of improving the appearance, ensuring eradication of the tumor, and reducing the possibility of recurrence. In addition, we have a case in which atypical changes were confirmed by histological examination in fractional surgery. A long follow-up period is recommended considering the high propensity and mean time to recurrence. Although malignant transformation of MD is rare occurrence, it occurred in 1 of the 16 patients.

[1]  Wei-Qiang Tan,et al.  Madelung's Disease: Lipectomy or Liposuction? , 2018, BioMed research international.

[2]  K. Błochowiak,et al.  The use of high tumescent power assisted liposuction in the treatment of Madelung’s collar , 2017, Postepy dermatologii i alergologii.

[3]  M. Correia,et al.  Madelung’s Disease: Revision of 59 Surgical Cases , 2017, Aesthetic Plastic Surgery.

[4]  N. Sharma,et al.  A surgical view on the treatment of Madelung's disease , 2015, Clinical obesity.

[5]  J. Zins,et al.  Syndromic Lipomatosis of the Head and Neck: A Review of the Literature , 2015, Aesthetic Plastic Surgery.

[6]  G. Sergi,et al.  Multiple symmetric lipomatosis: a rare disease and its possible links to brown adipose tissue. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[7]  S. Berkovic,et al.  Multiple Symmetrical Lipomatosis--a mitochondrial disorder of brown fat. , 2013, Mitochondrion.

[8]  J. Cameselle-Teijeiro,et al.  Madelung’s Disease: Comorbidities, Fatty Mass Distribution, and Response to Treatment of 22 Patients , 2013, Aesthetic Plastic Surgery.

[9]  G. Ferrandina,et al.  Malignant transformation of Madelung’s disease in a patient with a coincidental diagnosis of breast cancer: a case report , 2012, Diagnostic Pathology.

[10]  J. Yi,et al.  Surgical treatment of multiple symmetric lipomatosis (Madelung's disease): a single-center experience. , 2011, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[11]  Wen-lin Xiao,et al.  Madelung disease: manifestations of CT and MR imaging. , 2008, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[12]  R. González-García,et al.  Benign Symmetric Lipomatosis (Madelung’s Disease): Case Reports and Current Management , 2004, Aesthetic Plastic Surgery.

[13]  J. Ficker,et al.  Launois-Bensaude syndrome in a female with type 2 diabetes. , 2003, Medical science monitor : international medical journal of experimental and clinical research.

[14]  E. Nisoli,et al.  Multiple symmetric lipomatosis may be the consequence of defective noradrenergic modulation of proliferation and differentiation of brown fat cells , 2002, The Journal of pathology.

[15]  J. Ficker,et al.  Insulin resistance, hyperleptinemia, and obstructive sleep apnea in Launois-Bensaude syndrome. , 2002, Obesity research.

[16]  S. Gibelli,et al.  Madelung's Lipomatosis Associated with Head and Neck Malignant Neoplasia: A Study of 2 Cases , 2002, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[17]  G. Enzi,et al.  Multiple symmetric lipomatosis: clinical aspects and outcome in a long-term longitudinal study , 2002, International Journal of Obesity.

[18]  G. Szabó,et al.  Long-term results following surgical treatment of benign symmetric lipomatosis (BSL). , 2001, International journal of oral and maxillofacial surgery.

[19]  G. Vescio,et al.  Madelung's disease: case report and discussion of treatment options. , 2001, Annals of plastic surgery.

[20]  E. Pérez-Llantada,et al.  Benign symmetric lipomatosis (Madelung's disease). , 2000, European journal of internal medicine.

[21]  N. McMillan,et al.  Multiple Symmetric Lipomatosis--MR appearances. , 1999, Clinical radiology.

[22]  A. King,et al.  Head and Neck Cancers Associated With Madelung’s Disease , 1999, Annals of Surgical Oncology.

[23]  G. Redaelli,et al.  [Benign symmetrical lipomatosis: Madelung's disease]. , 1997, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[24]  M. Agrez,et al.  Benign symmetric lipomatosis. , 1995, The Australian and New Zealand journal of surgery.

[25]  C. Calle,et al.  [Changes in the mechanism of action of insulin on fatty tissue accumulations in lipomas, Madelung's lipomatosis and liposarcoma]. , 1992, Anales de medicina interna.

[26]  E. Shoubridge,et al.  Mitochondrial dysfunction in multiple symmetrical lipomatosis , 1991, Annals of neurology.

[27]  O. Braun-falco,et al.  [Benign symmetric Launois-Bensaude type III lipomatosis and Bureau-Barrière syndrome]. , 1991, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[28]  M. Pollock,et al.  NEUROPATHY IN MULTIPLE SYMMETRIC LIPOMATOSIS , 1988 .

[29]  M. Pollock,et al.  Neuropathy in multiple symmetric lipomatosis. Madelung's disease. , 1988, Brain : a journal of neurology.

[30]  T. Peters,et al.  MULTIPLE SYMMETRIC LIPOMATOSIS (LAUNOIS‐BENSAUDE SYNDROME): EFFECT OF ORAL SALBUTAMOL , 1987, Clinical endocrinology.

[31]  M. Landthaler,et al.  Benign symmetric lipomatosis Launois-Bensaude. Report of ten cases and review of the literature. , 1987, Journal of the American Academy of Dermatology.

[32]  C. Angelini,et al.  Sensory, Motor, and Autonomic Neuropathy in Patients with Multiple Symmetric Lipomatosis , 1985, Medicine.

[33]  K. Vykoupil,et al.  Malignant degeneration in Madelung's disease (benign lipomatosis of the neck): case report. , 1983, British journal of plastic surgery.

[34]  R. N. Alsever,et al.  Benign symmetric lipomatosis: functional sympathetic denervation of adipose tissue and possible hypertrophy of brown fat. , 1974, Metabolism: clinical and experimental.